We are live on ! Find out more
MCM

Marathon Capital Management Portfolio holdings

AUM $494M
1-Year Est. Return 42.6%
This Fund
S&P 500
This Quarter Est. Return
+10.44%
1 Year Est. Return
+42.6%
3 Year Est. Return
+70.91%
5 Year Est. Return
+55.81%
10 Year Est. Return
+429.8%
AUM
$245M
AUM Growth
+$21.3M
Cap. Flow
+$3.16M
Cap. Flow %
1.29%
Top 10 Hldgs %
67.31%
Holding
121
New
11
Increased
28
Reduced
53
Closed
9

Top Buys

Rank Stock Value
1
MYGN icon
Myriad Genetics
MYGN
+$2.24M
2
CVS icon
CVS Health
CVS
+$2.2M
3
NOK icon
Nokia
NOK
+$2M
4
ROKU icon
Roku
ROKU
+$1.16M
5
TPIC
TPI Composites
TPIC
+$980K

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$2.65M
2
CRCM
CARE.COM, INC.
CRCM
+$2.02M
3
ORBC
ORBCOMM, Inc.
ORBC
+$765K
4
ENPH icon
Enphase Energy
ENPH
+$516K
5
ENZ
Enzo Biochem, Inc.
ENZ
+$404K

Sector Composition

Rank Sector Weight
1 Financials 56.13%
2 Technology 17.14%
3 Healthcare 6.89%
4 Energy 5.17%
5 Industrials 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
26
DELISTED
Celgene Corp
CELG
$1.64M 0.67%
17,740
-575
-3% -$54.6K
WY icon
27
Weyerhaeuser
WY
$17.6B
$1.59M 0.65%
60,536
+663
+1% +$16.9K
PG icon
28
Procter & Gamble
PG
$340B
$1.44M 0.59%
13,130
-130
-1% -$13.9K
USB icon
29
US Bancorp
USB
$97.9B
$1.33M 0.54%
25,445
+300
+1% +$15.5K
TSEM icon
30
Tower Semiconductor
TSEM
$21.2B
$1.32M 0.54%
83,775
-1,050
-1% -$17.5K
ROKU icon
31
Roku
ROKU
$21.6B
$1.31M 0.53%
+14,420
New +$1.16M
GLUU
32
DELISTED
Glu Mobile Inc.
GLUU
$1.21M 0.49%
168,650
-3,350
-2% -$30.8K
WAAS
33
DELISTED
AquaVenture Holdings Limited
WAAS
$1.2M 0.49%
59,950
+19,200
+47% +$366K
MGY icon
34
Magnolia Oil & Gas
MGY
$5.93B
$1.16M 0.47%
100,565
-1,950
-2% -$23.9K
ZYME icon
35
Zymeworks
ZYME
$1.62B
$1.15M 0.47%
+52,175
New +$958K
PSX icon
36
Phillips 66
PSX
$82.9B
$1.14M 0.46%
12,162
+1,895
+18% +$170K
STX icon
37
Seagate
STX
$173B
$1.1M 0.45%
23,313
-250
-1% -$11.6K
TTGT icon
38
TechTarget
TTGT
$327M
$1.08M 0.44%
50,825
-1,300
-2% -$24.3K
VOD icon
39
Vodafone
VOD
$37.1B
$1.01M 0.41%
61,721
-8,395
-12% -$144K
RLH
40
DELISTED
Red Lions Hotel Corporation
RLH
$1.01M 0.41%
141,640
-17,450
-11% -$134K
TPIC
41
DELISTED
TPI Composites
TPIC
$946K 0.39%
+38,295
New +$980K
BMY icon
42
Bristol-Myers Squibb
BMY
$129B
$913K 0.37%
20,137
+6,230
+45% +$290K
AMZN icon
43
Amazon
AMZN
$2.44T
$901K 0.37%
9,520
-20
-0.2% -$1.86K
MRK icon
44
Merck
MRK
$322B
$894K 0.36%
11,175
-120
-1% -$9.19K
AEG icon
45
Aegon
AEG
$13.3B
$872K 0.36%
198,597
-13,893
-7% -$59.1K
ENZ
46
DELISTED
Enzo Biochem, Inc.
ENZ
$832K 0.34%
247,130
-114,766
-32% -$404K
BECN
47
DELISTED
Beacon Roofing Supply, Inc.
BECN
$805K 0.33%
21,940
+25
+0.1% +$906
BCX icon
48
BlackRock Resources & Commodities Strategy Trust
BCX
$896M
$802K 0.33%
98,159
-750
-0.8% -$5.95K
SHYF
49
DELISTED
The Shyft Group
SHYF
$783K 0.32%
71,500
-13,700
-16% -$126K
ORBC
50
DELISTED
ORBCOMM, Inc.
ORBC
$741K 0.3%
102,318
-107,459
-51% -$765K
1
2
3 4 5

Similar funds

LI
Lafayette Investments Ashton, Maryland $494M AUM 11.42% 1-Year Est. Return
SAS
Stelac Advisory Services New York $494M AUM 23.25% 1-Year Est. Return
BFIC
Bedell Frazier Investment Counselling Walnut Creek, California $495M AUM 29.32% 1-Year Est. Return
BPIA
Broad Peak Investment Advisers Singapore $493M AUM 143.71% 1-Year Est. Return
FSA
Financial Sense Advisors San Diego, California $493M AUM 50.68% 1-Year Est. Return
TAM
Talaria Asset Management Melbourne, Australia $495M AUM 21.62% 1-Year Est. Return
CH
Canton Hathaway Providence, Rhode Island $496M AUM 14.21% 1-Year Est. Return
TAA
Turiya Advisors Asia Hong Kong $496M AUM 75.42% 1-Year Est. Return

Marathon Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Marathon Capital Management held 121 positions worth $245M, up 9.5% from $224M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Marathon Capital Management's Q2 2019 filing shows 11 new, 28 increased, 53 reduced and 9 closed positions. Its largest new stake was Myriad Genetics: 79,460 shares worth $2.21M. The largest sale was DuPont de Nemours, an estimated $2.65M.

By sector, the portfolio is most concentrated in Financials at 56% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.

  • Marathon Capital Management's largest Q2 2019 buy was Myriad Genetics: 79,460 shares worth $2.21M.
  • Marathon Capital Management added most to Nokia in Q2 2019, an estimated $2M increase.
  • Marathon Capital Management's biggest Q2 2019 reduction was ORBCOMM, Inc., cutting an estimated $765K.
  • Marathon Capital Management fully exited DuPont de Nemours in Q2 2019, selling an estimated $2.65M.
  • Marathon Capital Management's ten largest holdings make up 67% of its $245M portfolio in Q2 2019.
  • Marathon Capital Management opened 11 new positions and closed 9 in Q2 2019.
  • Marathon Capital Management's portfolio value rose 9.5% quarter-over-quarter to $245M.

Based on Marathon Capital Management's 13F filing for Q2 2019, filed 25 Jul 2019.